A new study attempted to quantify the economic burden of early progression in patients with newly-diagnosed multiple myeloma. READ MORE
An international expert panel of hematologic oncologists have offered consensus recommendations for the diagnosis, treatment, and management of hairy cell leukemia.
Current value frameworks issued by leading medical societies may not be easily generalizable to the treatment of hematologic malignancies.
Patients with acute myeloid leukemia (AML) whose cells carry TP53 mutations may survive longer if they are treated with decitabine.